In 1963, before the advent of institutional review boards (IRBs),I was a young academic physician studying the regulation ofsodium excretion by the kidneys. I paid medical students approximately$50 to serve as subjects for experiments involving only salineinfusions and the collection of blood and spontaneously voidedurine samples. I do not remember exactly what I told the studentsabout the risks of the experiments but am quite certain thatI characterized them as nominal. In one subject, severe phlebitisdeveloped at the site of an intravenous infusion and requiredextensive therapy. The research project was funded by . . . [Full Text of this Article]
Conflicts of Interest and the Safety of Research Subjects
Stell, L. K.
(2009). Drug reps off campus! Promoting professional purity by suppressing commercial speech.. J Law Med Ethics
37: 431-443
Holloway, R. G., Mooney, C. J., Getchius, T.S.D., Edlund, W. S., Miyasaki, J. O.
(2008). Invited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines. Neurology
71: 57-63
[Abstract][Full Text]
Gray, S. W., Hlubocky, F. J., Ratain, M. J., Daugherty, C. K.
(2007). Attitudes Toward Research Participation and Investigator Conflicts of Interest Among Advanced Cancer Patients Participating in Early Phase Clinical Trials. JCO
25: 3488-3494
[Abstract][Full Text]
Jacobs, J. J., Galante, J. O., Mirza, S. K., Zdeblick, T.
(2006). Symposium. Relationships with Industry: Critical for New Technology or an Unnecessary Evil?. JBJS
88: 1650-1663
[Full Text]
Henry, D., Doran, E., Kerridge, I., Hill, S., McNeill, P. M., Day, R.
(2005). Ties That Bind: Multiple Relationships Between Clinical Researchers and the Pharmaceutical Industry. Arch Intern Med
165: 2493-2496
[Abstract][Full Text]
Camilleri, M., Gamble, G. L., Kopecky, S. L., Wood, M. B., Hockema, M. L.
(2005). Principles and Process in the Development of the Mayo Clinic's Individual and Institutional Conflict of Interest Policy. Mayo Clin Proc.
80: 1340-1346
[Abstract]
Kimmelman, J, Palmour, N
(2005). Therapeutic optimism in the consent forms of phase 1 gene transfer trials: an empirical analysis. J. Med. Ethics
31: 209-214
[Abstract][Full Text]
Alpert, J. S., Shine, K. I., Adams, R. J., Antman, E. M., Kavey, R. E. W., Friedman, L., Frye, R. L., Harrington, R. A., Korn, D., Merz, J. F., Ofili, E.
(2004). Task Force 1: The ACCF and AHA codes of conduct in human subjects research. J Am Coll Cardiol
44: 1724-1728
[Full Text]
Alpert, J. S., Shine, K. I., Adams, R. J., Antman, E. M., Kavey, R. E. W., Friedman, L., Frye, R. L., Harrington, R. A., Korn, D., Merz, J. F., Ofili, E.
(2004). Task Force 1: The ACCF and AHA Codes of Conduct in Human Subjects Research. Circulation
110: 2512-2516
[Full Text]
Levine, C., Faden, R., Grady, C., Hammerschmidt, D., Eckenwiler, L., Sugarman, J., on behalf of the Consortium to Examine Clinical Re,
(2004). "Special Scrutiny": A Targeted Form of Research Protocol Review. ANN INTERN MED
140: 220-223
[Abstract][Full Text]
Markman, M.
(2004). Ethical Conflict in Providing Informed Consent for Clinical Trials: A Problematic Example from the Gynecologic Cancer Research Community. The Oncologist
9: 3-7
[Abstract][Full Text]
Bekelman, J. E., Li, Y., Gross, C. P.
(2003). Scope and Impact of Financial Conflicts of Interest in Biomedical Research: A Systematic Review. JAMA
289: 454-465
[Abstract][Full Text]
Sollitto, S., Youngner, S., Lederman, M. M.
(2002). Nonfinancial Conflicts of Interest in Research. NEJM
347: 2173-2173
[Full Text]